Showing results (141-150 of 353) with videos related to

Sort By:
Pageof 36
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2016
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life settingKatja Kollewe, Claus M Escher, Dirk U Wulff, et al.
Journal of Neurology|July 11, 2018
Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetryLibin Xiao, Lizhen Pan, Bing Li, et al.
Biochimica Et Biophysica Acta|February 27, 2008
Inhibition of the ATPase activity of the catalytic portion of ATP synthases by cationic amphiphilesManuel J Datiles, Eric A Johnson, Richard E McCarty
The Journal of Biological Chemistry|October 17, 2006
Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1Nathan A Baird, Douglas W Turnbull, Eric A Johnson
Hybridoma (2005)|October 28, 2009
Characterization of the epitope region of F1-2 and F1-5, two monoclonal antibodies to Botulinum neurotoxin type AMiles C Scotcher, Eric A Johnson, Larry H Stanker
Journal of Neural Transmission (Vienna, Austria : 1996)|June 27, 2020
Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort studyAnna Kutschenko, Martin Klietz, Lejla Paracka, et al.
Movement Disorders Clinical Practice|August 27, 2025
Thalamic Deep Brain Stimulation for Dystonic Head Tremor: A Long-Term Study of 18 PatientsJohanna M Nagel, Marc E Wolf, Christian Blahak, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 31, 2026
Iatrogenic botulism: a risk for botulinum toxin's medical use?Dirk Dressler, Jürgen Frevert, Eric A Johnson, et al.
Plos Pathogens|April 13, 2011
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptorsLisheng Peng, William H Tepp, Eric A Johnson, et al.
Pageof 36